Sign Up to like & get
recommendations!
1
Published in 2022 at "In Vivo"
DOI: 10.21873/invivo.12812
Abstract: Background/Aim: Sorafenib has been reported to show anti-osteosarcoma (anti-OS) efficacy by inhibiting metastasis; however, a phase II trial suggested that further combination with other agents could be necessary to achieve permanent remission. Herein, we aimed…
read more here.
Keywords:
amentoflavone;
reinforcement sorafenib;
apoptosis;
anti osteosarcoma ... See more keywords